Droplet Microfluidic Screening for Non-Sterile Sample Phenotyping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying pathogenic microorganisms in non-sterile samples are inefficient, expensive, time-intensive, and require skilled personnel, as they struggle with commensal microorganisms and lack accuracy in phenotypic analysis.
Innovation Solution
Utilizing droplet microfluidics to generate small droplets containing viability indicators, allowing for rapid identification and quantification of microorganisms based on characteristic signatures, followed by phenotypic analysis of pathogenic species using droplet microfluidics and mass spectrometry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional phenotypic test methods (broth microdilution, disk diffusion) are used to determine antibiotic susceptibility, then accurate phenotypic response assessment is achieved, but additional culturing is required which lengthens analysis time
Solution Approach 1:
The patent performs preliminary culturing and pathogen isolation before phenotypic testing, so that when antibiotic susceptibility tests are conducted, the pathogens are already prepared and ready for immediate testing. This eliminates the need for additional culturing time during the actual phenotypic analysis, resolving the contradiction between accurate phenotypic assessment and analysis time.
2Measurement precision
If pathogenic microorganisms are isolated from commensal microorganisms using conventional methods (streaking), then accurate pathogen identification is achieved, but the process becomes time- and work-intensive requiring skilled personnel
Solution Approach 1:
The patent replaces manual mechanical streaking methods with automated systems including flow cytometry and robotic handling. These automated systems can differentiate and isolate pathogenic microorganisms from commensals based on physiological characteristics without requiring manual skilled operations, thereby maintaining identification accuracy while dramatically improving productivity and reducing personnel skill requirements.
3Measurement precision
If quantitative culture methods are used to identify and quantify microorganisms, then microorganism identification is achieved, but it requires 1 to 2 days for culturing and growth
Solution Approach 1:
The system performs preliminary enrichment culturing optimized for rapid pathogen growth, and simultaneously prepares detection reagents and calibration standards in advance. This allows the actual identification process to begin immediately upon sample receipt, reducing the total turnaround time from 1-2 days to a much shorter period while maintaining identification accuracy.
Solution Approach 2:
The patent replaces traditional visual inspection methods with automated detection systems including flow cytometry, spectral analysis, and machine learning-based image recognition. These systems can rapidly analyze microorganism characteristics without waiting for extensive cultural growth, thereby reducing culturing time while preserving identification precision.
4Loss of time
If QPCR is used for pathogen identification, then rapid identification is achieved, but it is expensive and may only identify some pathogens
Solution Approach 1:
The patent employs a universal detection platform based on flow cytometry and spectral analysis that can identify multiple types of pathogens (bacteria, fungi, parasites) through common physiological and optical characteristics. This multi-functional system replaces the need for pathogen-specific QPCR assays, providing both rapid identification and broad pathogen coverage at lower cost.
Solution Approach 2:
The system substitutes expensive QPCR instrumentation with more cost-effective flow cytometry and optical detection systems. These systems achieve comparable or superior identification speed while expanding pathogen detection capability across diverse microbial types without requiring multiple specialized instruments or expensive reagents.
5Loss of time
If NAATs are used for antibiotic resistance assessment, then genetic information analysis is performed, but accuracy is reduced compared to phenotypic methods because resistance mechanisms can evolve
Solution Approach 1:
The system performs preliminary phenotypic exposure tests where pathogens are exposed to antibiotics and their actual growth responses are measured in real-time. This preliminary phenotypic data serves as the gold standard for resistance assessment, capturing evolved resistance mechanisms that genetic tests might miss, while maintaining rapid testing throughput through automated monitoring.
Solution Approach 2:
The patent replaces genotypic NAAT testing with phenotypic flow cytometry-based growth assays. These assays directly measure the functional response of pathogens to antibiotics by monitoring cell division, membrane integrity, or metabolic activity in real-time. This substitution maintains high accuracy for detecting evolved resistance mechanisms while preserving rapid testing capability through automated high-throughput analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, cost-effective, and accurate identification and phenotypic analysis of pathogenic microorganisms, reducing the need for lengthy cultures and skilled labor, and improving differentiation between pathogenic and commensal species.
Implementation Method 1
generating a plurality of droplets from a liquid that includes a viability indicator and the first portion of the sample, wherein each of one or more microorganisms of the first portion of the sample is encapsulated within one of the droplets
Implementation Method 2
capturing a first set of data indicative of an identity and a quantity of the one or more microorganisms of the first portion of the sample
Implementation Method 3
phenotypic analysis of pathogenic species using droplet microfluidics and mass spectrometry
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
A method of analyzing a sample comprising one or more species of microorganisms can include generating first droplets such that each of one or more microorganisms of a first portion of the sample is encapsulated within one of the first droplets and, for each of one or more aliquots of a second portion of the sample, second droplets such that each of one or more microorganisms of the aliquot is encapsulated within one of the second droplets. First and second sets of data can be captured, the first set indicative of the identity and quantity of encapsulated microorganism(s) of the first portion of the sample and the second set indicative of a phenotypic response of encapsulated microorganism(s) of the aliquot(s) to one or more test reagents. A target species' phenotypic response to the test reagent(s) is determinable at least by referencing the second data set to the first data set.